PharmaFrontiers Corp., of Houston, appointed Tony Kamin to its board.
Phyton Biotech Inc., of Ithaca, N.Y., appointed Charles Swindell vice president of research and development.
Saegis Pharmaceuticals Inc., of Half Moon Bay, Calif., appointed Ann Neale vice president of clinical operations.
Spectranetics Corp., of Colorado Springs, Colo., appointed Craig Walker to its board.
Spectrum Pharmaceuticals Inc., of Irvine, Calif., appointed Stuart Krassner to its board.
Tapestry Pharmaceuticals Inc., of Boulder, Colo., appointed Elliot Maza to its board.
Tm Bioscience Corp., of Toronto, appointed Daynna Wolff to its scientific advisory board.
Ventaira Pharmaceuticals Inc., of Columbus, Ohio, promoted Leslie Williams to president and CEO.
Viropro Pharma, of Montreal, appointed Max Bergoin to its scientific advisory committee.